FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082187751> ?p ?o ?g. }

• W3082187751 abstract "Abstract Blood-brain barrier (BBB) disruption is a common feature in neurodegenerative diseases. However, BBB integrity has not been assessed in spinocerebellar ataxias (SCAs) such as Machado-Joseph disease/SCA type 3 (MJD/SCA3), a genetic disorder, triggered by polyglutamine-expanded ataxin-3. To investigate that, BBB integrity was evaluated in a transgenic mouse model of MJD and in human post-mortem brain tissues. Firstly, we investigated the BBB permeability in MJD mice by: i) assessing the extravasation of the Evans blue (EB) dye and blood-borne proteins (e.g fibrinogen) in the cerebellum by immunofluorescence, and ii) in vivo Dynamic Contrast Enhanced-Magnetic Resonance Imaging (DCE-MRI). The presence of ataxin-3 aggregates in brain blood vessels and the levels of tight junction (TJ)-associated proteins were also explored by immunofluorescence and western blotting. Human brain samples were used to confirm BBB permeability by evaluating fibrinogen extravasation, co-localization of ataxin-3 aggregates with brain blood vessels and neuroinflammation. In the cerebellum of the mouse model of MJD, there was a 5-fold increase in EB accumulation when compared to age-matched controls. Moreover, vascular permeability displayed a 13-fold increase demonstrated by DCE-MRI. These results were validated by the 2-fold increase in fibrinogen extravasation in transgenic animals comparing to controls. Interestingly, mutant ataxin-3 aggregates were detected in cerebellar blood vessels of transgenic mice, accompanied by alterations of TJ-associated proteins in cerebellar endothelial cells, namely a 29% decrease in claudin-5 oligomers and a 10-fold increase in an occludin cleavage fragment. These results were validated in post-mortem brain samples from MJD patients as we detected fibrinogen extravasation across BBB, the presence of ataxin-3 aggregates in blood vessels and associated microgliosis. Altogether, our results prove BBB impairment in MJD/SCA3. These findings contribute for a better understanding of the disease mechanisms and opens the opportunity to treat MJD with medicinal products that in normal conditions would not cross the BBB." @default.
• W3082187751 created "2020-09-08" @default.
• W3082187751 creator A5006888400 @default.
• W3082187751 creator A5033651655 @default.
• W3082187751 creator A5043517773 @default.
• W3082187751 creator A5045668678 @default.
• W3082187751 creator A5054123993 @default.
• W3082187751 creator A5054608866 @default.
• W3082187751 creator A5062004674 @default.
• W3082187751 creator A5087727256 @default.
• W3082187751 creator A5091005808 @default.
• W3082187751 date "2020-08-31" @default.
• W3082187751 modified "2023-10-14" @default.
• W3082187751 title "The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples" @default.
• W3082187751 cites W1837885345 @default.
• W3082187751 cites W1938210552 @default.
• W3082187751 cites W1965402655 @default.
• W3082187751 cites W1966244775 @default.
• W3082187751 cites W1985455477 @default.
• W3082187751 cites W1992758695 @default.
• W3082187751 cites W1996358781 @default.
• W3082187751 cites W2005142390 @default.
• W3082187751 cites W2006965597 @default.
• W3082187751 cites W2012458146 @default.
• W3082187751 cites W2017816173 @default.
• W3082187751 cites W2024150064 @default.
• W3082187751 cites W2024171930 @default.
• W3082187751 cites W2025064470 @default.
• W3082187751 cites W2026318673 @default.
• W3082187751 cites W2029530107 @default.
• W3082187751 cites W2030985020 @default.
• W3082187751 cites W2034275438 @default.
• W3082187751 cites W2037444978 @default.
• W3082187751 cites W2042811939 @default.
• W3082187751 cites W2046440333 @default.
• W3082187751 cites W2047723850 @default.
• W3082187751 cites W2055467683 @default.
• W3082187751 cites W2056350794 @default.
• W3082187751 cites W2073012734 @default.
• W3082187751 cites W2081664686 @default.
• W3082187751 cites W2085230868 @default.
• W3082187751 cites W2095592075 @default.
• W3082187751 cites W2097961311 @default.
• W3082187751 cites W2098051394 @default.
• W3082187751 cites W2099040590 @default.
• W3082187751 cites W2102573354 @default.
• W3082187751 cites W2105028929 @default.
• W3082187751 cites W2106229319 @default.
• W3082187751 cites W2121979986 @default.
• W3082187751 cites W2124702644 @default.
• W3082187751 cites W2133395047 @default.
• W3082187751 cites W2136412949 @default.
• W3082187751 cites W2137546687 @default.
• W3082187751 cites W2143452090 @default.
• W3082187751 cites W2148853271 @default.
• W3082187751 cites W2151483206 @default.
• W3082187751 cites W2160759052 @default.
• W3082187751 cites W2160954000 @default.
• W3082187751 cites W2165575517 @default.
• W3082187751 cites W2187837306 @default.
• W3082187751 cites W2216083821 @default.
• W3082187751 cites W2274800116 @default.
• W3082187751 cites W2367767229 @default.
• W3082187751 cites W2418677760 @default.
• W3082187751 cites W2462279034 @default.
• W3082187751 cites W2512114264 @default.
• W3082187751 cites W2559475643 @default.
• W3082187751 cites W2592585693 @default.
• W3082187751 cites W2613908362 @default.
• W3082187751 cites W2614810773 @default.
• W3082187751 cites W2738968781 @default.
• W3082187751 cites W2766949297 @default.
• W3082187751 cites W2791041386 @default.
• W3082187751 cites W2808454816 @default.
• W3082187751 cites W2810678568 @default.
• W3082187751 cites W2883369902 @default.
• W3082187751 cites W2889807583 @default.
• W3082187751 cites W2903475294 @default.
• W3082187751 cites W2910494574 @default.
• W3082187751 cites W2911147760 @default.
• W3082187751 cites W2913231079 @default.
• W3082187751 cites W2919929253 @default.
• W3082187751 cites W2949780361 @default.
• W3082187751 cites W3010897162 @default.
• W3082187751 cites W63651712 @default.
• W3082187751 doi "https://doi.org/10.1186/s40478-020-00955-0" @default.
• W3082187751 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7457506" @default.
• W3082187751 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32867861" @default.
• W3082187751 hasPublicationYear "2020" @default.
• W3082187751 type Work @default.
• W3082187751 sameAs 3082187751 @default.
• W3082187751 citedByCount "11" @default.
• W3082187751 countsByYear W30821877512020 @default.
• W3082187751 countsByYear W30821877512021 @default.
• W3082187751 countsByYear W30821877512022 @default.
• W3082187751 countsByYear W30821877512023 @default.
• W3082187751 crossrefType "journal-article" @default.
• W3082187751 hasAuthorship W3082187751A5006888400 @default.
• W3082187751 hasAuthorship W3082187751A5033651655 @default.
• W3082187751 hasAuthorship W3082187751A5043517773 @default.

• next